Preterm Delivery
Gastroenterology
6
Pipeline Programs
3
Companies
3
Clinical Trials
3
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
1
3
Early DiscoveryClinical DevelopmentMarket
On Market (3)
Approved therapies currently available
U
PROGESTASERTApproved
progesterone
Unknown Companyintrauterine1976
U
PROGESTERONEApproved
progesterone
Unknown CompanyProgesterone [EPC]oral2017
U
PROMETRIUMApproved
progesterone
Unknown Companyoral1998
Competitive Landscape
3 companies ranked by most advanced pipeline stage
AB
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
T-Therapeuticsprogesterone
Ferring PharmaceuticalsMerotocin
AP BiosciencesProgesterone
Clinical Trials (3)
Total enrollment: 4 patients across 3 trials
Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor
Start: Jul 2006Est. completion: Dec 2012
Phase 3Terminated
Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely
Start: May 2021Est. completion: Nov 20224 patients
Phase 2Terminated
Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?
Start: Jun 2006Est. completion: Sep 2010
Phase 2Completed
Related Jobs in Gastroenterology
Specialty Representative, Gastroenterology – Minneapolis, Minnesota
AbbVie
Remote
13h ago
Head of Drug Product Development
Ironwood Pharmaceuticals
Boston, Massachusetts, United States
15h ago
$246K - $287K/yr
Regulatory Affairs Associate
Ferring Pharmaceuticals
Istanbul, Turkey
Yesterday
Key Account Director, Diagnostics and Research
Tempus
Remote
Yesterday
$150K - $200K/yr
Senior Sterilization Validation Engineer (m/f/d)
Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday
Senior Financial Analyst - Supply Chain Finance & Transformation (m/f/d)
Johnson & Johnson
Norderstedt, Schleswig-Holstein, Germany
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space